APO Research
Talk to an analyst

APO RESEARCH · REPORT

New Drug for Alzheimer's Treatment

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global New Drug for Alzheimer's Treatment Market Outlook and Growth Opportunities 2026

29 December 2025198 pages

Choose your research edition.

Industry ResearchNew Drug for Alzheimer's Treatment Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal New Drug for Alzheimer's Treatment Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal New Drug for Alzheimer's Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal New Drug for Alzheimer's Treatment Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal New Drug for Alzheimer's Treatment Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global New Drug for Alzheimer's Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for New Drug for Alzheimer's Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for New Drug for Alzheimer's Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for New Drug for Alzheimer's Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the New Drug for Alzheimer's Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the New Drug for Alzheimer's Treatment market include Simcere, Eisai, Johnson and Johnson, Green Valley, Roche, Eli Lilly, Biogen, AstraZeneca and Vivoryon, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global New Drug for Alzheimer's Treatment market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of New Drug for Alzheimer's Treatment and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents New Drug for Alzheimer's Treatment sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the New Drug for Alzheimer's Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

New Drug for Alzheimer's Treatment Segment by Company

Simcere

Eisai

Johnson and Johnson

Green Valley

Roche

Eli Lilly

Biogen

AstraZeneca

Vivoryon

Neurimmune

New Drug for Alzheimer's Treatment Segment by Type

AChE Target

Aβ Target

BChE Target

Others

New Drug for Alzheimer's Treatment Segment by Application

Mild Cognitive Impairment Stage

Preclinical Stage

Dementia Stage

New Drug for Alzheimer's Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global New Drug for Alzheimer's Treatment status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions New Drug for Alzheimer's Treatment market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify New Drug for Alzheimer's Treatment significant trends, drivers, influence factors in global and regions.

6. To analyze New Drug for Alzheimer's Treatment competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global New Drug for Alzheimer's Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of New Drug for Alzheimer's Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of New Drug for Alzheimer's Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the New Drug for Alzheimer's Treatment market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global New Drug for Alzheimer's Treatment industry.

Chapter 3: Detailed analysis of New Drug for Alzheimer's Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of New Drug for Alzheimer's Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of New Drug for Alzheimer's Treatment in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. New Drug for Alzheimer's Treatment Industry Trends Table 2. New Drug for Alzheimer's Treatment Industry Drivers Table 3. New Drug for Alzheimer's Treatment Industry Opportunities and Challenges Table 4. New Drug for Alzheimer's Treatment Industry Restraints Table 5. Global New Drug for Alzheimer's Treatment Revenue by Company (US$ Million) & (2021-2026) Table 6. Global New Drug for Alzheimer's Treatment Revenue Share by Company (2021-2026) Table 7. Global New Drug for Alzheimer's Treatment Sales Volume by Company (K Units) & (2021-2026) Table 8. Global New Drug for Alzheimer's Treatment Sales Volume Share by Company (2021-2026) Table 9. Global New Drug for Alzheimer's Treatment Average Price (US$/Unit) of Company (2021-2026) Table 10. Global New Drug for Alzheimer's Treatment Company Ranking, (2024-2026) & (USD Million) Table 11. Global New Drug for Alzheimer's Treatment Key Company Manufacturing Base & Headquarters Table 12. Global New Drug for Alzheimer's Treatment Company, Product Type & Application Table 13. Global New Drug for Alzheimer's Treatment Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global New Drug for Alzheimer's Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of AChE Target Table 18. Significant Companies of Aβ Target Table 19. Significant Companies of BChE Target Table 20. Significant Companies of Others Table 21. Global New Drug for Alzheimer's Treatment Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global New Drug for Alzheimer's Treatment Sales Volume by Type (2021-2026) & (K Units) Table 23. Global New Drug for Alzheimer's Treatment Sales Volume by Type (2027-2032) & (K Units) Table 24. Global New Drug for Alzheimer's Treatment Sales Volume Share by Type (2021-2026) Table 25. Global New Drug for Alzheimer's Treatment Sales Volume Share by Type (2027-2032) Table 26. Global New Drug for Alzheimer's Treatment Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global New Drug for Alzheimer's Treatment Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global New Drug for Alzheimer's Treatment Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global New Drug for Alzheimer's Treatment Sales Value Share by Type (2021-2026) Table 30. Global New Drug for Alzheimer's Treatment Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Mild Cognitive Impairment Stage Table 32. Significant Companies of Preclinical Stage Table 33. Significant Companies of Dementia Stage Table 34. Global New Drug for Alzheimer's Treatment Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global New Drug for Alzheimer's Treatment Sales Volume by Application (2021-2026) & (K Units) Table 36. Global New Drug for Alzheimer's Treatment Sales Volume by Application (2027-2032) & (K Units) Table 37. Global New Drug for Alzheimer's Treatment Sales Volume Share by Application (2021-2026) Table 38. Global New Drug for Alzheimer's Treatment Sales Volume Share by Application (2027-2032) Table 39. Global New Drug for Alzheimer's Treatment Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global New Drug for Alzheimer's Treatment Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global New Drug for Alzheimer's Treatment Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global New Drug for Alzheimer's Treatment Sales Value Share by Application (2021-2026) Table 43. Global New Drug for Alzheimer's Treatment Sales Value Share by Application (2027-2032) Table 44. Global New Drug for Alzheimer's Treatment Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global New Drug for Alzheimer's Treatment Sales by Region (2021-2026) & (K Units) Table 46. Global New Drug for Alzheimer's Treatment Sales Market Share by Region (2021-2026) Table 47. Global New Drug for Alzheimer's Treatment Sales by Region (2027-2032) & (K Units) Table 48. Global New Drug for Alzheimer's Treatment Sales Market Share by Region (2027-2032) Table 49. Global New Drug for Alzheimer's Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global New Drug for Alzheimer's Treatment Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global New Drug for Alzheimer's Treatment Sales Value Share by Region (2021-2026) Table 52. Global New Drug for Alzheimer's Treatment Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global New Drug for Alzheimer's Treatment Sales Value Share by Region (2027-2032) Table 54. Global New Drug for Alzheimer's Treatment Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global New Drug for Alzheimer's Treatment Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global New Drug for Alzheimer's Treatment Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global New Drug for Alzheimer's Treatment Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global New Drug for Alzheimer's Treatment Sales by Country (2021-2026) & (K Units) Table 59. Global New Drug for Alzheimer's Treatment Sales Market Share by Country (2021-2026) Table 60. Global New Drug for Alzheimer's Treatment Sales by Country (2027-2032) & (K Units) Table 61. Global New Drug for Alzheimer's Treatment Sales Market Share by Country (2027-2032) Table 62. Global New Drug for Alzheimer's Treatment Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global New Drug for Alzheimer's Treatment Sales Value Market Share by Country (2021-2026) Table 64. Global New Drug for Alzheimer's Treatment Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global New Drug for Alzheimer's Treatment Sales Value Market Share by Country (2027-2032) Table 66. Simcere Company Information Table 67. Simcere Business Overview Table 68. Simcere New Drug for Alzheimer's Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Simcere New Drug for Alzheimer's Treatment Product Portfolio Table 70. Simcere Recent Development Table 71. Eisai Company Information Table 72. Eisai Business Overview Table 73. Eisai New Drug for Alzheimer's Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Eisai New Drug for Alzheimer's Treatment Product Portfolio Table 75. Eisai Recent Development Table 76. Johnson and Johnson Company Information Table 77. Johnson and Johnson Business Overview Table 78. Johnson and Johnson New Drug for Alzheimer's Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Johnson and Johnson New Drug for Alzheimer's Treatment Product Portfolio Table 80. Johnson and Johnson Recent Development Table 81. Green Valley Company Information Table 82. Green Valley Business Overview Table 83. Green Valley New Drug for Alzheimer's Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Green Valley New Drug for Alzheimer's Treatment Product Portfolio Table 85. Green Valley Recent Development Table 86. Roche Company Information Table 87. Roche Business Overview Table 88. Roche New Drug for Alzheimer's Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Roche New Drug for Alzheimer's Treatment Product Portfolio Table 90. Roche Recent Development Table 91. Eli Lilly Company Information Table 92. Eli Lilly Business Overview Table 93. Eli Lilly New Drug for Alzheimer's Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Eli Lilly New Drug for Alzheimer's Treatment Product Portfolio Table 95. Eli Lilly Recent Development Table 96. Biogen Company Information Table 97. Biogen Business Overview Table 98. Biogen New Drug for Alzheimer's Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Biogen New Drug for Alzheimer's Treatment Product Portfolio Table 100. Biogen Recent Development Table 101. AstraZeneca Company Information Table 102. AstraZeneca Business Overview Table 103. AstraZeneca New Drug for Alzheimer's Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. AstraZeneca New Drug for Alzheimer's Treatment Product Portfolio Table 105. AstraZeneca Recent Development Table 106. Vivoryon Company Information Table 107. Vivoryon Business Overview Table 108. Vivoryon New Drug for Alzheimer's Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Vivoryon New Drug for Alzheimer's Treatment Product Portfolio Table 110. Vivoryon Recent Development Table 111. Neurimmune Company Information Table 112. Neurimmune Business Overview Table 113. Neurimmune New Drug for Alzheimer's Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Neurimmune New Drug for Alzheimer's Treatment Product Portfolio Table 115. Neurimmune Recent Development Table 116. Key Raw Materials Table 117. Raw Materials Key Suppliers Table 118. New Drug for Alzheimer's Treatment Distributors List Table 119. New Drug for Alzheimer's Treatment Customers List Table 120. Research Programs/Design for This Report Table 121. Authors List of This Report Table 122. Secondary Sources Table 123. Primary Sources List of Figures Figure 1. New Drug for Alzheimer's Treatment Product Image Figure 2. Global New Drug for Alzheimer's Treatment Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global New Drug for Alzheimer's Treatment Sales Value (2021-2032) & (US$ Million) Figure 4. Global New Drug for Alzheimer's Treatment Sales (2021-2032) & (K Units) Figure 5. Global New Drug for Alzheimer's Treatment Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global New Drug for Alzheimer's Treatment Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. AChE Target Image Figure 10. Aβ Target Image Figure 11. BChE Target Image Figure 12. Others Image Figure 13. Global New Drug for Alzheimer's Treatment Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global New Drug for Alzheimer's Treatment Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global New Drug for Alzheimer's Treatment Sales Volume Share by Type (2021-2032) Figure 16. Global New Drug for Alzheimer's Treatment Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global New Drug for Alzheimer's Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global New Drug for Alzheimer's Treatment Sales Value Share by Type (2021-2032) Figure 19. Mild Cognitive Impairment Stage Image Figure 20. Preclinical Stage Image Figure 21. Dementia Stage Image Figure 22. Global New Drug for Alzheimer's Treatment Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global New Drug for Alzheimer's Treatment Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global New Drug for Alzheimer's Treatment Sales Volume Share by Application (2021-2032) Figure 25. Global New Drug for Alzheimer's Treatment Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global New Drug for Alzheimer's Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global New Drug for Alzheimer's Treatment Sales Value Share by Application (2021-2032) Figure 28. Global New Drug for Alzheimer's Treatment Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global New Drug for Alzheimer's Treatment Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global New Drug for Alzheimer's Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global New Drug for Alzheimer's Treatment Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America New Drug for Alzheimer's Treatment Sales Value (2021-2032) & (US$ Million) Figure 33. North America New Drug for Alzheimer's Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe New Drug for Alzheimer's Treatment Sales Value (2021-2032) & (US$ Million) Figure 35. Europe New Drug for Alzheimer's Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific New Drug for Alzheimer's Treatment Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific New Drug for Alzheimer's Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America New Drug for Alzheimer's Treatment Sales Value (2021-2032) & (US$ Million) Figure 39. South America New Drug for Alzheimer's Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa New Drug for Alzheimer's Treatment Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa New Drug for Alzheimer's Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. New Drug for Alzheimer's Treatment Value Chain Figure 127. Manufacturing Cost Structure Figure 128. New Drug for Alzheimer's Treatment Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • AChE Target
  • Aβ Target
  • BChE Target
  • Others
Applications
  • Mild Cognitive Impairment Stage
  • Preclinical Stage
  • Dementia Stage
Companies covered
  • Simcere
  • Eisai
  • Johnson and Johnson
  • Green Valley
  • Roche
  • Eli Lilly
  • Biogen
  • AstraZeneca
  • Vivoryon
  • Neurimmune

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global New Drug for Alzheimer's Treatment Sales Value (2021-2032)
  4. 1.2.2 Global New Drug for Alzheimer's Treatment Sales Volume (2021-2032)
  5. 1.2.3 Global New Drug for Alzheimer's Treatment Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 New Drug for Alzheimer's Treatment Market Dynamics
  1. 2.1 New Drug for Alzheimer's Treatment Industry Trends
  2. 2.2 New Drug for Alzheimer's Treatment Industry Drivers
  3. 2.3 New Drug for Alzheimer's Treatment Industry Opportunities and Challenges
  4. 2.4 New Drug for Alzheimer's Treatment Industry Restraints
3 New Drug for Alzheimer's Treatment Market by Company
  1. 3.1 Global New Drug for Alzheimer's Treatment Company Revenue Ranking in 2025
  2. 3.2 Global New Drug for Alzheimer's Treatment Revenue by Company (2021-2026)
  3. 3.3 Global New Drug for Alzheimer's Treatment Sales Volume by Company (2021-2026)
  4. 3.4 Global New Drug for Alzheimer's Treatment Average Price by Company (2021-2026)
  5. 3.5 Global New Drug for Alzheimer's Treatment Company Ranking (2024-2026)
  6. 3.6 Global New Drug for Alzheimer's Treatment Company Manufacturing Base and Headquarters
  7. 3.7 Global New Drug for Alzheimer's Treatment Company Product Type and Application
  8. 3.8 Global New Drug for Alzheimer's Treatment Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global New Drug for Alzheimer's Treatment Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 New Drug for Alzheimer's Treatment Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 New Drug for Alzheimer's Treatment Market by Type
  1. 4.1 New Drug for Alzheimer's Treatment Type Introduction
  2. 4.1.1 AChE Target
  3. 4.1.2 Aβ Target
  4. 4.1.3 BChE Target
  5. 4.1.4 Others
  6. 4.2 Global New Drug for Alzheimer's Treatment Sales Volume by Type
  7. 4.2.1 Global New Drug for Alzheimer's Treatment Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global New Drug for Alzheimer's Treatment Sales Volume by Type (2021-2032)
  9. 4.2.3 Global New Drug for Alzheimer's Treatment Sales Volume Share by Type (2021-2032)
  10. 4.3 Global New Drug for Alzheimer's Treatment Sales Value by Type
  11. 4.3.1 Global New Drug for Alzheimer's Treatment Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global New Drug for Alzheimer's Treatment Sales Value by Type (2021-2032)
  13. 4.3.3 Global New Drug for Alzheimer's Treatment Sales Value Share by Type (2021-2032)
5 New Drug for Alzheimer's Treatment Market by Application
  1. 5.1 New Drug for Alzheimer's Treatment Application Introduction
  2. 5.1.1 Mild Cognitive Impairment Stage
  3. 5.1.2 Preclinical Stage
  4. 5.1.3 Dementia Stage
  5. 5.2 Global New Drug for Alzheimer's Treatment Sales Volume by Application
  6. 5.2.1 Global New Drug for Alzheimer's Treatment Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global New Drug for Alzheimer's Treatment Sales Volume by Application (2021-2032)
  8. 5.2.3 Global New Drug for Alzheimer's Treatment Sales Volume Share by Application (2021-2032)
  9. 5.3 Global New Drug for Alzheimer's Treatment Sales Value by Application
  10. 5.3.1 Global New Drug for Alzheimer's Treatment Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global New Drug for Alzheimer's Treatment Sales Value by Application (2021-2032)
  12. 5.3.3 Global New Drug for Alzheimer's Treatment Sales Value Share by Application (2021-2032)
6 New Drug for Alzheimer's Treatment Regional Sales and Value Analysis
  1. 6.1 Global New Drug for Alzheimer's Treatment Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global New Drug for Alzheimer's Treatment Sales by Region (2021-2032)
  3. 6.2.1 Global New Drug for Alzheimer's Treatment Sales by Region: 2021-2026
  4. 6.2.2 Global New Drug for Alzheimer's Treatment Sales by Region (2027-2032)
  5. 6.3 Global New Drug for Alzheimer's Treatment Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global New Drug for Alzheimer's Treatment Sales Value by Region (2021-2032)
  7. 6.4.1 Global New Drug for Alzheimer's Treatment Sales Value by Region: 2021-2026
  8. 6.4.2 Global New Drug for Alzheimer's Treatment Sales Value by Region (2027-2032)
  9. 6.5 Global New Drug for Alzheimer's Treatment Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America New Drug for Alzheimer's Treatment Sales Value (2021-2032)
  12. 6.6.2 North America New Drug for Alzheimer's Treatment Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe New Drug for Alzheimer's Treatment Sales Value (2021-2032)
  15. 6.7.2 Europe New Drug for Alzheimer's Treatment Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific New Drug for Alzheimer's Treatment Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific New Drug for Alzheimer's Treatment Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America New Drug for Alzheimer's Treatment Sales Value (2021-2032)
  21. 6.9.2 South America New Drug for Alzheimer's Treatment Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa New Drug for Alzheimer's Treatment Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa New Drug for Alzheimer's Treatment Sales Value Share by Country, 2025 VS 2032
7 New Drug for Alzheimer's Treatment Country-level Sales and Value Analysis
  1. 7.1 Global New Drug for Alzheimer's Treatment Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global New Drug for Alzheimer's Treatment Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global New Drug for Alzheimer's Treatment Sales by Country (2021-2032)
  4. 7.3.1 Global New Drug for Alzheimer's Treatment Sales by Country (2021-2026)
  5. 7.3.2 Global New Drug for Alzheimer's Treatment Sales by Country (2027-2032)
  6. 7.4 Global New Drug for Alzheimer's Treatment Sales Value by Country (2021-2032)
  7. 7.4.1 Global New Drug for Alzheimer's Treatment Sales Value by Country (2021-2026)
  8. 7.4.2 Global New Drug for Alzheimer's Treatment Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt New Drug for Alzheimer's Treatment Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt New Drug for Alzheimer's Treatment Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt New Drug for Alzheimer's Treatment Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Simcere
  2. 8.1.1 Simcere Company Information
  3. 8.1.2 Simcere Business Overview
  4. 8.1.3 Simcere New Drug for Alzheimer's Treatment Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Simcere New Drug for Alzheimer's Treatment Product Portfolio
  6. 8.1.5 Simcere Recent Developments
  7. 8.2 Eisai
  8. 8.2.1 Eisai Company Information
  9. 8.2.2 Eisai Business Overview
  10. 8.2.3 Eisai New Drug for Alzheimer's Treatment Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Eisai New Drug for Alzheimer's Treatment Product Portfolio
  12. 8.2.5 Eisai Recent Developments
  13. 8.3 Johnson and Johnson
  14. 8.3.1 Johnson and Johnson Company Information
  15. 8.3.2 Johnson and Johnson Business Overview
  16. 8.3.3 Johnson and Johnson New Drug for Alzheimer's Treatment Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Johnson and Johnson New Drug for Alzheimer's Treatment Product Portfolio
  18. 8.3.5 Johnson and Johnson Recent Developments
  19. 8.4 Green Valley
  20. 8.4.1 Green Valley Company Information
  21. 8.4.2 Green Valley Business Overview
  22. 8.4.3 Green Valley New Drug for Alzheimer's Treatment Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Green Valley New Drug for Alzheimer's Treatment Product Portfolio
  24. 8.4.5 Green Valley Recent Developments
  25. 8.5 Roche
  26. 8.5.1 Roche Company Information
  27. 8.5.2 Roche Business Overview
  28. 8.5.3 Roche New Drug for Alzheimer's Treatment Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Roche New Drug for Alzheimer's Treatment Product Portfolio
  30. 8.5.5 Roche Recent Developments
  31. 8.6 Eli Lilly
  32. 8.6.1 Eli Lilly Company Information
  33. 8.6.2 Eli Lilly Business Overview
  34. 8.6.3 Eli Lilly New Drug for Alzheimer's Treatment Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Eli Lilly New Drug for Alzheimer's Treatment Product Portfolio
  36. 8.6.5 Eli Lilly Recent Developments
  37. 8.7 Biogen
  38. 8.7.1 Biogen Company Information
  39. 8.7.2 Biogen Business Overview
  40. 8.7.3 Biogen New Drug for Alzheimer's Treatment Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Biogen New Drug for Alzheimer's Treatment Product Portfolio
  42. 8.7.5 Biogen Recent Developments
  43. 8.8 AstraZeneca
  44. 8.8.1 AstraZeneca Company Information
  45. 8.8.2 AstraZeneca Business Overview
  46. 8.8.3 AstraZeneca New Drug for Alzheimer's Treatment Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 AstraZeneca New Drug for Alzheimer's Treatment Product Portfolio
  48. 8.8.5 AstraZeneca Recent Developments
  49. 8.9 Vivoryon
  50. 8.9.1 Vivoryon Company Information
  51. 8.9.2 Vivoryon Business Overview
  52. 8.9.3 Vivoryon New Drug for Alzheimer's Treatment Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Vivoryon New Drug for Alzheimer's Treatment Product Portfolio
  54. 8.9.5 Vivoryon Recent Developments
  55. 8.10 Neurimmune
  56. 8.10.1 Neurimmune Company Information
  57. 8.10.2 Neurimmune Business Overview
  58. 8.10.3 Neurimmune New Drug for Alzheimer's Treatment Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Neurimmune New Drug for Alzheimer's Treatment Product Portfolio
  60. 8.10.5 Neurimmune Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 New Drug for Alzheimer's Treatment Value Chain Analysis
  2. 9.1.1 New Drug for Alzheimer's Treatment Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 New Drug for Alzheimer's Treatment Sales Mode & Process
  6. 9.2 New Drug for Alzheimer's Treatment Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 New Drug for Alzheimer's Treatment Distributors
  9. 9.2.3 New Drug for Alzheimer's Treatment Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst